AstraZeneca scores twin drug approvals alongside vaccine progress
(Reuters) – Britain’s AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in…
Blackstone raises three-quarters of targeted $4.6 billion life sciences fund
FILE PHOTO: The ticker and trading information for Blackstone Group is displayed at the post where it is traded on…
Too old? Too slow? No! Debut marathoners may add years to life
LONDON (Reuters) – First-time marathon runners can add years to their lives and reap the health rewards of lower blood…
Explainer: Making a new generation of ‘guided-missile’ cancer drugs work
FRANKFURT (Reuters) – A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The…
Bristol-Myers wins $752 million in U.S. patent case against Gilead
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage,…
CVS to increase genetic testing for some cancer patients
(This December 12 story corrects to Missouri from Montana in last paragraph) By Caroline Humer and Julie Steenhuysen NEW YORK…
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after…
CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after…
New Roche flu drug can drive resistance in influenza viruses: researchers
CHICAGO (Reuters) – Roche’s influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a…
Longer-term data fail to clear concern over Takeda’s dengue vaccine
CHICAGO (Reuters) – An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co’s experimental dengue vaccine…
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end…
Roche tests ‘brain shuttle’ in humans in Alzheimer’s project
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Scientists find how deadly malaria parasite jumped from gorillas to humans
LONDON (Reuters) – Scientists who resurrected a 50,000-year-old gene sequence have analyzed it to figure out how the world’s deadliest…
U.S. agents raid genetic testing labs, charge 35 in Medicare fraud probe
WASHINGTON/LAWRENCEVILLE, Ga. (Reuters) – U.S. federal agents raided genetic testing laboratories, and 35 people were criminally charged in four states…
Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: study
(Reuters) – About 40% of patients who received a combination of Bristol-Myers Squibb Co’s immuno-oncology drugs Opdivo and Yervoy as…
Targeted Amgen drug has low response rate in colon cancer in study
(Reuters) – An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12…
Results of GSK and AstraZeneca trials may widen ovarian cancer drug use
BARCELONA (Reuters) – GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a…
Novartis wins FDA’s breakthrough tag for lung cancer hopeful
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect”…
Ebola survivors face kidney problems and risk of premature death
LONDON (Reuters) – People who survive Ebola virus infection face a dramatically higher risk of dying – probably from severe…
Genetic study implicates humans in demise of prehistoric cave bear
WASHINGTON (Reuters) – Genetic research that reconstructed the past population dynamics of the cave bear, a prominent prehistoric denizen of…
Roche’s personalized cancer treatment wins FDA approval
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever…
Roche says test showed Tecentriq helped vs bladder cancer
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor
(Reuters) – The U.S. Food and Drug Administration on Friday approved Daiichi Sankyo Co Ltd’s treatment for adult patients with…
Pandemic bonds face scrutiny after Ebola outbreak yet to trigger payout
LONDON (Reuters) – World Bank funding instruments issued to help emerging countries swiftly tackle pandemics have come under the spotlight…
Roche’s Tecentriq recommended for EU approval to treat lung cancer form
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
WHO says it could use more U.S. help on the ground in Ebola fight
GENEVA (Reuters) – The United States could bolster the battle against the Ebola virus in Democratic Republic of Congo by…
Bristol-Myers releases mixed Opdivo lung cancer results
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage,…
WHO says investigators conclude Ebola victim did not enter Rwanda
GENEVA (Reuters) – A Congolese woman who may have spread the deadly Ebola virus in Uganda did not go to…
Timeline: How a Congo Ebola outbreak became a global concern
DAKAR (Reuters) – The World Health Organization has declared Congo’s Ebola outbreak an international health emergency, after the virus threatened…
WHO sounds Ebola alarm as risks intensify
GENEVA (Reuters) – The World Health Organization on Wednesday declared Congo’s Ebola outbreak an international health emergency, sounding a rarely…
WHO flags Ebola risk in Rwanda, but then withdraws its report
GENEVA (Reuters) – The World Health Organization on Thursday withdrew a report that said an Ebola patient may have entered…
Ebola spread to east Congo’s Goma massively raises risk – U.N.
GOMA, Democratic Republic of Congo/GENEVA (Reuters) – Ebola’s arrival in eastern Congo’s main city of Goma severely raises the risk…
UK offers HPV vaccines to boys, aims to stop 100,000 cancer cases
FILE PHOTO: An illustration picture shows a Gardasil anti-cervical cancer vaccine box displayed at a pharmacy in Strasbourg November 25,…
Roche’s combo lymphoma treatment wins U.S. FDA approval
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Takeda scraps late-stage amyloidosis study
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled…
Parkinson’s drug trial offers glimmer of hope for brain cells
LONDON, Feb 27 (Reuters) – An experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients, scientists…
Savencia unit recalls baby milk in France after salmonella alert
PARIS (Reuters) – Sodilac, a unit of French dairy group Savencia, said it was recalling infant formula sold in pharmacies…
China orders halt to gene-editing after outcry over babies
SHANGHAI (Reuters) – The Chinese government on Thursday ordered a temporary halt to research activities for people involved in the…
Congo Republic confirms yellow fever near Angolan enclave
BRAZZAVILLE (Reuters) – Congo Republic has confirmed a case of yellow fever near the border with an Angolan enclave, the…
West Nile virus cases in Greece jump in 2018
ATHENS (Reuters) – Eleven people have died and 107 infected by the mosquito-borne West Nile virus in Greece so far…
Long-acting injection a shot in the arm for GSK’s HIV business
LONDON (Reuters) – A long-acting injection developed by GlaxoSmithKline (GSK.L) and given once a month has proved as effective as…
Congo declares new Ebola outbreak in eastern province
GOMA, Democratic Republic of Congo (Reuters) – Four people have tested positive for Ebola in eastern Democratic Republic of Congo…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on…
CRISPR gene editing can cause risky collateral DNA damage: study
LONDON (Reuters) – Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause…
Medical workers in Congo city finish vaccinating contacts of Ebola patients
KINSHASA (Reuters) – Medical workers in Democratic Republic of Congo have given all the immediate contacts of Ebola patients in…
Bayer launches $7 billion cash call to fund Monsanto deal
BERLIN (Reuters) – Bayer (BAYGn.DE) launched a 6 billion euros ($7 billion) rights issue on Sunday, a cornerstone of the…
Many women with early-stage breast cancer can skip chemotherapy: study
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can…
India steps up hunt for origin of mysterious brain-damaging virus
MUMBAI/KOCHI (Reuters) – India began a fresh round of tests to trace the origin of a rare brain-damaging virus that…
Ebola patients slip out of Congo hospital as medics try to control outbreak
MBANDAKA, Democratic Republic of Congo (Reuters) – Three patients infected with the Ebola virus slipped out of an isolation ward…
Two more die of Ebola in Congo, seven new cases confirmed
MBANDAKA, Democratic Republic of Congo (Reuters) – Two more people have died from Ebola and seven new cases were confirmed…
Congo begins giving experimental Ebola vaccine to medics
MBANDAKA, Democratic Republic of Congo (Reuters) – Congo began administering an experimental Ebola vaccine to medical staff in the northwestern…
Hungarian laboratory worker isolated after exposure to Ebola virus
BUDAPEST (Reuters) – A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly…